The last time medicine had a new “ray” was back when radioactivity was king, spawning nuclear medicine and grade-B sci-fi flicks. Before the gamma ray was the x-ray . . . and that goes way back.
The last time medicine had a new "ray" was back when radioactivity was king, spawning nuclear medicine and grade-B sci-fi flicks. Before the gamma ray was the x-ray . . . and that goes way back.
So it is with some excitement that I am now reading about the t-ray. This relatively unused photon hails from a region of the electromagnetic spectrum between infrared and microwave, the terahertz region, with frequencies from 0.1 to 10 terahertz. And there's plenty to get excited about.
T-rays don't pose the same health risks as x-rays. Unlike ultrasound, terahertz transmitters don't have to contact the skin to send those rays into the body. And, like MR, t-rays can gather spectroscopic information about the composition of materials, especially in biological tissues.
A sobering fact, however, is that this region of the electromagnetic spectrum is not so much new as it is unused. Scientists have been fiddling with it for more than 20 years. A big hitch in efforts to get t-rays into practical use, any practical use, has been the size and weight of t-ray generators, which have been built around high-powered lasers that are very heavy, very big, and very expensive.
That's where Brian Schulkin comes in. A doctoral student in physics at Rensselaer Polytechnic Institute, Schulkin has developed a handheld terahertz spectrometer that he calls the Mini-Z.
It's been used already to detect cracks in space shuttle foam, spot counterfeit watermarks on paper currency, and image tumors in breast tissue, according to RTI. The system weighs less than five pounds and is small enough to fit in a briefcase. With the weight and size issues out of the way, only one problem remains: the fact that t-rays represent a disruptive technology. And that, right off the bat, is strike one against it.
Disruptive technologies don't fare well in medicine. When they do break into clinical practice, they usually take a long time to be accepted, and, even then, conditions have to be just right. Take PET, for instance, the last disruptive technology to gain a foothold in medical imaging. More than two decades passed from the time the first image was made at Washington University in the 1970s until PET became widely available.
It can't be argued that medical imaging lags far behind other industries in the adoption of new technologies. Part of it, certainly, is the regulatory hoops through which manufacturers must jump. But what constitutes the rest of the wall over which new ideas must be thrown to enter medical practice? What is it that keeps new ideas out? And what can be done about it?
Answers to these questions could have as much impact on the practice of medicine and the evolution of medical imaging as the handheld Mini-Z . . . maybe more.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.